Phagocytosis of Plasmodium falciparum ring-stage parasites predicts protection against malaria.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
14 07 2022
Historique:
received: 08 02 2021
accepted: 27 06 2022
entrez: 14 7 2022
pubmed: 15 7 2022
medline: 19 7 2022
Statut: epublish

Résumé

Ring-infected erythrocytes are the predominant asexual stage in the peripheral circulation but are rarely investigated in the context of acquired immunity against Plasmodium falciparum malaria. Here we compare antibody-dependent phagocytosis of ring-infected parasite cultures in samples from a controlled human malaria infection (CHMI) study (NCT02739763). Protected volunteers did not develop clinical symptoms, maintained parasitaemia below a predefined threshold of 500 parasites/μl and were not treated until the end of the study. Antibody-dependent phagocytosis of both ring-infected and uninfected erythrocytes from parasite cultures was strongly correlated with protection. A surface proteomic analysis revealed the presence of merozoite proteins including erythrocyte binding antigen-175 and -140 on ring-infected and uninfected erythrocytes, providing an additional antibody-mediated protective mechanism for their activity beyond invasion-inhibition. Competition phagocytosis assays support the hypothesis that merozoite antigens are the key mediators of this functional activity. Targeting ring-stage parasites may contribute to the control of parasitaemia and prevention of clinical malaria.

Identifiants

pubmed: 35835738
doi: 10.1038/s41467-022-31640-6
pii: 10.1038/s41467-022-31640-6
pmc: PMC9281573
doi:

Substances chimiques

Antibodies, Protozoan 0
Antigens, Protozoan 0

Banques de données

ClinicalTrials.gov
['NCT02739763']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4098

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : EPA
ID : EP-C-15-003
Pays : United States
Organisme : Wellcome Trust
ID : 107499
Pays : United Kingdom
Organisme : Department of Health
ID : 16/136/33
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 107769/Z/10/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 107754/Z/15/Z
Pays : United Kingdom

Investigateurs

Abdirahman I Abdi (AI)
Yonas Abebe (Y)
Philip Bejon (P)
Peter F Billingsley (PF)
Peter C Bull (PC)
Zaydah de Laurent (Z)
Stephen L Hoffman (SL)
Eric R James (ER)
Silvia Kariuki (S)
Rinter Kimathi (R)
Sam Kinyanjui (S)
Cheryl Kivisi (C)
Johnstone Makale (J)
Kevin Marsh (K)
Khadija Said Mohammed (KS)
Moses Mosobo (M)
Janet Musembi (J)
Jennifer Musyoki (J)
Michelle Muthui (M)
Jedidah Mwacharo (J)
Francis Ndungu (F)
Joyce M Ngoi (JM)
Omar Ngoto (O)
Bernhards Ogutu (B)
Fredrick Olewe (F)
Donwilliams Omuoyo (D)
John Ong'echa (J)
Edward Otieno (E)
Jimmy Shangala (J)
Betty Kim Lee Sim (BKL)
Thomas L Richie (TL)
Juliana Wambua (J)
Thomas N Williams (TN)

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2022. The Author(s).

Références

Infect Immun. 1999 May;67(5):2334-9
pubmed: 10225892
Am J Trop Med Hyg. 2001 Sep;65(3):197-203
pubmed: 11561704
PLoS One. 2013 Sep 09;8(9):e74627
pubmed: 24040299
Malar J. 2018 Aug 20;17(1):304
pubmed: 30126436
J Infect Dis. 2007 Aug 15;196(4):617-21
pubmed: 17624849
Lancet. 1997 Jun 7;349(9066):1650-4
pubmed: 9186382
J Cell Biol. 1988 May;106(5):1507-13
pubmed: 2453514
Blood. 2008 Sep 15;112(6):2520-8
pubmed: 18579796
Wellcome Open Res. 2018 Dec 6;3:155
pubmed: 31803847
Elife. 2017 Feb 21;6:
pubmed: 28221136
Nat Med. 2000 Nov;6(11):1264-8
pubmed: 11062539
Elife. 2017 Sep 26;6:
pubmed: 28949293
NPJ Vaccines. 2020 Jun 9;5(1):48
pubmed: 32566259
Infect Immun. 2007 Nov;75(11):5500-8
pubmed: 17785475
Malar J. 2018 Oct 19;17(1):371
pubmed: 30340592
Malar J. 2009 Jul 30;8:179
pubmed: 19642995
Clin Vaccine Immunol. 2017 Feb 6;24(2):
pubmed: 27881488
Elife. 2017 Mar 02;6:
pubmed: 28252384
Cell. 2016 Oct 20;167(3):610-624
pubmed: 27768886
Parasite Immunol. 2011 Feb;33(2):104-15
pubmed: 21226723
FEMS Microbiol Rev. 2016 May;40(3):343-72
pubmed: 26833236
Elife. 2017 Mar 02;6:
pubmed: 28252383
Acta Trop. 2009 Dec;112(3):295-302
pubmed: 19695213
Nat Protoc. 2009;4(12):1899-915
pubmed: 20010926
Proc Natl Acad Sci U S A. 1996 Apr 16;93(8):3503-8
pubmed: 8622966
Cell Host Microbe. 2017 Aug 9;22(2):232-245
pubmed: 28799908
PLoS One. 2016 Sep 19;11(9):e0163066
pubmed: 27644034
JCI Insight. 2021 Sep 8;6(17):
pubmed: 34264864
Mol Biochem Parasitol. 1988 Jun;29(2-3):251-60
pubmed: 3045543
J Infect Dis. 2019 Feb 15;219(5):819-828
pubmed: 30365004
PLoS One. 2015 Apr 30;10(4):e0117820
pubmed: 25927360
Infect Immun. 2008 May;76(5):2240-8
pubmed: 18316390
BMC Med. 2014 Jul 01;12:108
pubmed: 24980799
Immunol Rev. 1982;61:245-69
pubmed: 6174413
Clin Exp Immunol. 1982 Mar;47(3):635-44
pubmed: 7044626
PLoS One. 2012;7(6):e38523
pubmed: 22675573
Nat Commun. 2012 Feb 14;3:674
pubmed: 22334077
Br Med J. 1954 Feb 6;1(4857):290-4
pubmed: 13115700
J Exp Med. 1984 Jun 1;159(6):1686-704
pubmed: 6374012
Curr Mol Med. 2006 Mar;6(2):187-203
pubmed: 16515510
J Clin Invest. 2012 Sep;122(9):3227-38
pubmed: 22850879
Nat Protoc. 2016 Dec;11(12):2301-2319
pubmed: 27809316
Clin Exp Immunol. 1992 Dec;90(3):357-62
pubmed: 1458672
Clin Vaccine Immunol. 2010 Oct;17(10):1552-9
pubmed: 20702657
Malar J. 2016 May 31;15:301
pubmed: 27245446
Sci Transl Med. 2019 Jan 9;11(474):
pubmed: 30626712
Blood. 2006 May 1;107(9):3745-52
pubmed: 16384927
Trends Parasitol. 2016 Nov;32(11):887-898
pubmed: 27546781
Nat Rev Immunol. 2020 Oct;20(10):633-643
pubmed: 32782358
J Exp Med. 1990 Jul 1;172(1):379-82
pubmed: 1694225
Parasitol Int. 2016 Oct;65(5 Pt B):549-551
pubmed: 27600143
Mol Microbiol. 2001 Jul;41(1):47-58
pubmed: 11454199
Mol Cell Proteomics. 2014 Sep;13(9):2513-26
pubmed: 24942700
PLoS Clin Trials. 2006 Oct 20;1(6):e29
pubmed: 17053830
Nat Protoc. 2006;1(6):2856-60
pubmed: 17406544
Blood. 2005 Nov 15;106(10):3632-8
pubmed: 16046531
PLoS One. 2011 Apr 14;6(4):e18393
pubmed: 21533224
Science. 1985 Nov 1;230(4725):553-6
pubmed: 3901257
Proc Natl Acad Sci U S A. 2010 Aug 10;107(32):14378-83
pubmed: 20660744
Blood. 2003 Jun 15;101(12):5025-32
pubmed: 12609837

Auteurs

Fauzia K Musasia (FK)

Centre for Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany.

Irene N Nkumama (IN)

Centre for Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany.
Centre for Geographic Medicine Research (Coast), Kenya Medical Research Institute (KEMRI)-Wellcome Trust Research Programme, Kilifi, Kenya.

Roland Frank (R)

Centre for Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany.

Victor Kipkemboi (V)

Centre for Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany.
Department of Biotechnology, Hochschule Rhein-Waal, Kleve, Germany.

Martin Schneider (M)

Genomics and Proteomics Core Facility, German Cancer Research Center, Heidelberg, Germany.

Kennedy Mwai (K)

Centre for Geographic Medicine Research (Coast), Kenya Medical Research Institute (KEMRI)-Wellcome Trust Research Programme, Kilifi, Kenya.
Epidemiology and Biostatistics Division, School of Public Health, University of the Witwatersrand, Johannesburg, South Africa.

Dennis O Odera (DO)

Centre for Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany.
Centre for Geographic Medicine Research (Coast), Kenya Medical Research Institute (KEMRI)-Wellcome Trust Research Programme, Kilifi, Kenya.

Micha Rosenkranz (M)

Centre for Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany.

Kristin Fürle (K)

Centre for Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany.

Domitila Kimani (D)

Centre for Geographic Medicine Research (Coast), Kenya Medical Research Institute (KEMRI)-Wellcome Trust Research Programme, Kilifi, Kenya.

James Tuju (J)

Centre for Geographic Medicine Research (Coast), Kenya Medical Research Institute (KEMRI)-Wellcome Trust Research Programme, Kilifi, Kenya.

Patricia Njuguna (P)

Centre for Geographic Medicine Research (Coast), Kenya Medical Research Institute (KEMRI)-Wellcome Trust Research Programme, Kilifi, Kenya.

Mainga Hamaluba (M)

Centre for Geographic Medicine Research (Coast), Kenya Medical Research Institute (KEMRI)-Wellcome Trust Research Programme, Kilifi, Kenya.

Melissa C Kapulu (MC)

Centre for Geographic Medicine Research (Coast), Kenya Medical Research Institute (KEMRI)-Wellcome Trust Research Programme, Kilifi, Kenya.

Hedda Wardemann (H)

Division of B Cell Immunology, German Cancer Research Center, Heidelberg, Germany.

Faith H A Osier (FHA)

Centre for Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany. f.osier@imperial.ac.uk.
Centre for Geographic Medicine Research (Coast), Kenya Medical Research Institute (KEMRI)-Wellcome Trust Research Programme, Kilifi, Kenya. f.osier@imperial.ac.uk.
Department of Life Sciences, Imperial College London, London, UK. f.osier@imperial.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH